Computational biology researchers at MSKCC recently announced a new, freely available Internet tool for the exploration of the scientific literature in medicine and biology.
The 85,000-square-foot outpatient cancer treatment facility is the Center's largest ambulatory care facilty in its regional network, which also includes sites on Long Island in Commack, Rockville Centre, and Hauppauge and in Westchester County in Sleepy Hollow.
Thanks to advances in medicine and an increased focus on nutrition and exercise, Americans are expected to live longer lives than their predecessors. This good news is tempered by the fact that the incidence of cancer rises exponentially as the population ages. MSKCC is working at the forefront of the effort to prepare for this new reality.
Recent studies suggest that RNA, which directs the synthesis of vital proteins, is subject to damage and repair. Now a collaboration between researchers in the Sloan-Kettering Institute and the Tri-Institutional Training Program in Chemical Biology has led to the exquisite visualization of one of these repair enzymes.
A study led by MSKCC immunologist Marcel R. van den Brink has demonstrated a novel strategy for boosting numbers of infection-fighting T cells in mice after allogeneic bone marrow transplantation. The results indicate the feasibility of using this approach to improve immune response in human transplant recipients.
Joan Massague, Chair of the Cancer Biology and Genetics Program in the Sloan-Kettering Institute, has been elected a member of the Institute of Medicine.
News@MSKCC provides journalists with news and information from Memorial Sloan-Kettering Cancer Center and is released six times a year.
For more information about these and other potential story ideas, contact Memorial Sloan-Kettering's Department of Public Affairs at: 212-639-3573 or at mediastaff@mskcc.org
